Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06551324 |
Title | A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). (MEVPRO-1) |
Acronym | MEVPRO-1 |
Recruitment | Recruiting |
Gender | male |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Pfizer |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | AUS |